Navigation Links
Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
Date:2/21/2009

BEDFORD, Mass., Feb. 11 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, today reported financial results for its fourth quarter and year ended December 31, 2008.

Revenues for the fourth quarter of 2008 were $12.1 million, an increase of 79% compared to $6.8 million in the same quarter last year. For the year ended December 31, 2008, revenues increased 15% to $30.5 million, compared to $26.4 million in 2007.

The Company reports its net income and basic and diluted net income per share in accordance with U.S. generally accepted accounting principles (GAAP), and additionally, on a non-GAAP basis. Non-GAAP net income, where applicable, excludes the effect of stock-based compensation expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be considered in isolation from, and are not a substitute for, GAAP measures. A reconciliation of GAAP to non-GAAP results has been provided in the attached financial tables.

GAAP net income for the fourth quarter of 2008 was $5.0 million, or $0.21 per diluted share, which included $0.4 million of stock-based compensation charges in accordance with the provisions of FAS 123(R). This compared to GAAP net income of $0.2 million, or $0.01 per diluted share, for the same period a year ago. GAAP net income for the year ended December 31, 2008 was $1.8 million, or $0.07 per diluted share, compared to net income of $0.2 million, or $0.01 per diluted share, for 2007.

Non-GAAP net income for the fourth quarter of 2008, excluding the effect of stock-base
'/>"/>

SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology news :

1. Sun Microsystems and Aware, Inc. Announce Integration of Awares BioSP with Sun Identity Management Solutions
2. Aware, Inc. Reports Fourth Quarter and 2007 Financial Results
3. Aware, Inc. Announces Richard Moberg to Return as CFO
4. Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture
5. GEN reports on strategies to overcome blood-brain barrier
6. GEN reports on growing reliance on microfluidics technology
7. Cytori reports benefit of adipose-derived regenerative cells in spinal disc model
8. GEN reports growing focus on PI3-kinase pathway in cancer research
9. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
10. Orchid Cellmark Reports Third Quarter 2008 Financial Results
11. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Eight of the top 10 U.S. cities that have ... public inconveniences as frequent road closures, overwhelmed storm drains ... a new NOAA technical report. , This nuisance flooding, ... three U.S. coasts, between 300 and 925 percent since ... Nuisance Flood Frequency Changes around the United States, also ...
(Date:7/28/2014)... study suggest two ways to effectively address the problem that ... women, compared to women of a normal body mass index. ... but as the population has increased in weight, concern has ... Studies have consistently found that obesity has a negative impact ... affect how well the pill prevents pregnancy. , ...
(Date:7/28/2014)... He calls himself the bug hunter, but the ... only be found and identified with special methods and ... Kansas State Veterinary Diagnostic Laboratory at Kansas State University, ... porcine enterovirus G, which is an important find in ... in cells, but didn,t know what it was," Hause ...
Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Strategies identified to improve oral contraceptive success with obese women 2Researcher using next-generation sequencing to rapidly identify pathogens 2Researcher using next-generation sequencing to rapidly identify pathogens 3
... Junrong Zheng,s techniques to see the fine details of how ... highly prestigious Packard Fellowship. Zheng and his team ... grant that comes with the fellowship to build a laser-based ... and orientation -- of any molecule, no matter how complex. ...
... BOSTON, MA (October 20, 2011) Results from a ... copper surfaces in intensive care unit rooms reduced the amount ... in a 41 percent reduction in the hospital acquired infection ... first to demonstrate the value of a passive infection control ...
... of Bristol has been awarded 1.3 million to unlock the ... to produce silica the fundamental constituent of glass. It ... the next generation of medical imaging tools. Inspired by ... Paul Curnow from the University,s School of Biochemistry has been ...
Cached Biology News:Rice's Zheng wins Packard Fellowship 2Study proves new technology kills bacteria 2
(Date:7/28/2014)... Calif. , July 28, 2014  InterMune, Inc. ... will release its second quarter 2014 financial results at ... 6, 2014. A live conference call and webcast will be ... same day. Interested investors and others may ... or +1 212-231-2900 (international), conference ID#21728775. A replay of the ...
(Date:7/25/2014)... 2014 "Ischemic Stroke and Cerebral ... data on the Ischemic Stroke and Cerebral Stroke ... and data relating to the clinical trials on ... global Ischemic Stroke Research Report 2014 at: ... the trial numbers and their recruitment status as ...
(Date:7/25/2014)... New York (PRWEB) July 25, 2014 ... Market Research, "Biological Drugs Market - Global Industry Analysis, ... the global biological drugs market is estimated at USD ... at a CAGR of 10.1% from 2014 to 2020, ... in 2020. , The biological drugs market is witnessing ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- Xybion Corporation, the ... global corporations operating in highly regulated industries, announced ... annual Global User Group Conference, Xybion International Exchange, ... Philadelphia, Pennsylvania at the Sheraton Society ... This year,s conference theme ...
Breaking Biology Technology:InterMune to Release Second Quarter Financial Results on August 6 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3
... Productivity. , ... Grand Forks, ND (Vocus) December 10, ... individual management practices and fields will become increasingly important to growers, ... Research and Development, will tell agricultural leaders today at the ...
... Dosing Regimen , , ... long-acting therapy (LAT) demonstrated statistically significant symptom control compared ... study presented today (1). Statistical significance was evidenced ... equivalent [eq.a]), when given every 4 weeks with a ...
... Journal Blood for the American Society of Hematology Annual Meeting ... 10 Alfacell Corporation (Nasdaq: ACEL ) today ... in Blood (2008 112: Abstract 4205 & 2008 ... show anti-tumor activity in chronic lymphocytic leukemia (CLL) and acute ...
Cached Biology Technology:Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops 2Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops 3Matching Genetics, Technology and Management Practices Critical to Meeting Strong Demand for Agricultural Crops 4Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 2Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 3Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 4Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 5Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 6Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 7Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 8Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia 9Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 2Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 3Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 4Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells 5
Rabbit polyclonal to Lck (phospho Y192) ( Abpromise for all tested applications). entrezGeneID: 3932 SwissProtID: P06239...
...
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: